Acuity Brands have signed a strategic alliance agreement with Ushio America, to bring the powerful germicidal technology (Care222 UV disinfection module) to North American customers.
The Care222 lamp module uses filtered excimer lamps to generate 222nm far-UVC light, will inactivate viruses and bacteria, as well as protect public areas. Acuity Brands plan to incorporate these lamps in its leading lighting fixtures, including ceiling and wall-mounted lighting fixtures that can operate in occupied or unoccupied spaces, to reduce pathogens. Meanwhile, Ushio will supply the Care222 UVC lighting fixtures throughout North America.
The mercury-free Care222 excimer lamps will emit intermittent pulses of the 222nm UV light that can inactivate viruses and bacteria. These lamps feature a specially designed short-pass filter, based on Columbia University’s research and technology, which strains out the longer UV wavelengths from the lamp that are harmful to humans. Importantly, laboratory testing and clinical studies suggest that these filtered UV lights pose no health risk to human skin or eyes when used within appropriate parameters.
Acuity Brands can exclusively use this module across North America and has non-exclusive right to launch it worldwide (except Asia) for lighting and other uses. Notably, it projects to introduce lighting fixtures featuring the Care222 module in late 2020.
Acuity Brands is highly focused on innovating new lighting solutions. The company boasts a diversified portfolio of innovative lighting control solutions and energy-efficient luminaries. In response to rapidly changing market trends, Acuity Brands is consistently expanding the portfolio of innovative lighting control solutions and energy-efficient luminaries.